Neuroscience News

Join us as we look back on some of the key studies we covered here at Wu Tsai Neuro and the Knight Initiative in 2025 to give a (very partial) overview of the impact of our community’s research efforts this past year

Neuroradiologist Raag Airan and his lab have found a non-invasive, drug-free method to help clean the brain, reduce inflammation, and treat disease—and with Knight Initiative for Brain Resilience support, they plan to test it in people soon.

Premature babies who heard recordings of their mothers reading to them had more mature white matter in a key language area of the brain, Wu Tsai Neuro affiliate Heidi Feldman and colleagues found.

What could make a promising approach to psychiatry and brain research even better? A solid beat.

A new study finds links between two popular models of the disease—and the results could change how researchers think about treatment.

Small cell lung cancer often metastasizes to the brain. A Stanford Medicine-led study shows the cancer cells form synapses with neurons, and signaling across these synapses encourages tumor growth.

Stanford researchers reviewed over 400 therapy evaluations and discovered a crucial mismatch: Mouse studies test disease prevention, while human trials test treatment of existing disease.

In a new study in rats, scientists used ultrasound-activated nanoparticles to deliver ketamine and anesthetics to precise targets in the brain.

The technique, which used genetically healthy donor cells, prolonged life and function in mice with a disease similar to Tay-Sachs.

Stanford Medicine researchers discuss the brain’s ancient wiring and how its built-in reward-seeking system can be hijacked by addiction—as well as ways to prevent and treat it.

The Global Neurodegeneration Proteomics Consortium gathered a trove of data on potential signs of neurological disease—and researchers including Knight Initiative director Tony Wyss-Coray are already using it to make new discoveries.

A blood-test analysis developed at Stanford Medicine can determine the “biological ages” of 11 separate organ systems in individuals’ bodies and predict the health consequences.

Research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson’s disease.

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, according to research by Wu Tsai Neuro affiliate Michelle Monje and colleagues. They also identified compounds that could treat it.

A new analysis of a vaccination program in Wales by a Knight Initiative–supported team found that the shingles vaccine appeared to lower new dementia diagnos

Psychiatrist Anna Lembke shares what scientists have discovered so far about the potential for GLP-1s in addiction treatment.